(Q34926082)

5 August 2017

1 reference

title

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations (English)

1 reference

Duchenne muscular dystrophy

5 August 2017

1 reference

inferred from title

author

Annemieke Aartsma-Rus

1

Annemieke Aartsma-Rus

0 references

Gert-Jan van Ommen

6

Gert-Jan van Ommen

0 references

Ivo Fac Fokkema

Ivo Fokkema

2

0 references

Jan J Verschuuren

Jan Verschuuren

3

1 reference

ORCID Public Data File 2021

author name string

Ieke Ginjaar

4

1 reference

5 August 2017

Judith van Deutekom

5

1 reference

5 August 2017

Gert-Jan van Ommen

6

1 reference

5 August 2017

Johan T den Dunnen

7

1 reference

5 August 2017

1 March 2009

1 reference

5 August 2017

1 reference

5 August 2017

30

1 reference

5 August 2017

3

1 reference

5 August 2017

293-299

1 reference

Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene

5 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Induction of revertant fibres in the mdx mouse using antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Skipping toward personalized molecular medicine

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

A Japanese boy with myalgia and cramps has a novel in-frame deletion of the dystrophin gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Induced dystrophin exon skipping in human muscle explants

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy".

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

A normal male with an inherited deletion of one exon within the DMD gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Improved molecular diagnosis of dystrophin gene mutations using the multiplex ligation-dependent probe amplification method.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Local dystrophin restoration with antisense oligonucleotide PRO051

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Advances in Duchenne muscular dystrophy gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20918

7 January 2021

Identifiers

DOI

10.1002/HUMU.20918

1 reference

release_26fifu2h4fh4xlmy47tw4ozho4

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/26fifu2h4fh4xlmy47tw4ozho4

24 November 2022

mapped directly with Wikidata item

1 reference